Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DI5K9S
|
|||
| Drug Name |
BNT164
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Tuberculosis [ICD-11: 1B10-1B14] | Phase 1 | [1] | |
| Company |
BioNTech
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05537038) A Phase Ia, Randomized, Placebo-controlled, Double-blind, Dose-finding Evaluation Trial to Describe the Safety, Reactogenicity, and Immunogenicity of Two Investigational Vaccines Against Tuberculosis in IGRA-negative, BCG na?ve Subjects. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.